Page 247 - Read Online

Qu et al. Etiological prevention of liver cancer

Homan C, Parkinson AJ. Elimination of hepatocellular carcinoma and 54. Wang Y, Chen T, Lu LL, Wang M, Wang D, Yao H, Fan C, Qi J,
acute hepatitis B in children 25 years after a hepatitis B newborn and Zhang Y, Qu C. Adolescent booster with hepatitis B virus vaccines
catch-up immunization program. Hepatology 2011;54:801-7. decreases HBV infection in high-risk adults. Vaccine 2017;35:1064-
37. Gwack J, Park SK, Lee EH, Park B, Choi Y, Yoo KY. Hepatitis B 70.
vaccination and liver cancer mortality reduction in Korean children 55. Romano’ L, Paladini S, Van Damme P, Zanetti AR. The worldwide
and adolescents. Asian Pac J Cancer Prev 2011;12:2205-8. impact of vaccination on the control and protection of viral hepatitis
38. Tajiri H, Tanaka H, Brooks S, Takano T. Reduction of hepatocellular B. Dig Liver Dis 2011;43 Suppl 1:S2-7.
carcinoma in childhood after introduction of selective vaccination 56. Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet
against hepatitis B virus for infants born to HBV carrier mothers. 2014;384:2053-63.
Cancer Causes Control 2011;22:523-7. 57. Locarnini S, Hatzakis A, Chen DS, Lok A. Strategies to control
39. Gao J, Xie L, Chen WQ, Zhang SW, Wu QJ, Yang Y, Yang WS, hepatitis B: Public policy, epidemiology, vaccine and drugs. J Hepatol
Tan YT, Xiang YB. Rural-urban, sex variations, and time trend of 2015;62:S76-86.
primary liver cancer incidence in China, 1988-2005. Eur J Cancer 58. Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, Kao JH, Lin
Prev 2013;22:448-54. YC, Chen HL, Hsu HY, Chen DS. Two decades of universal hepatitis
40. Zuo T, Zheng R, Zeng H, Zhang S, Chen W. Analysis of liver B vaccination in taiwan: impact and implication for future strategies.
cancer incidence and trend in China. Zhonghua Zhong Liu Za Zhi Gastroenterology 2007;132:1287-93.
2015;37:691-6. (in Chinese) 59. Pan CQ, Duan ZP, Bhamidimarri KR, Zou HB, Liang XF, Li J, Tong
41. Kurahashi N, Inoue M, Iwasaki M, Tanaka Y, Mizokami M, Tsugane MJ. An algorithm for risk assessment and intervention of mother to
S; JPHC Study Group. Vegetable, fruit and antioxidant nutrient child transmission of hepatitis B virus. Clin Gastroenterol Hepatol
consumption and subsequent risk of hepatocellular carcinoma: a 2012;10:452-9.
prospective cohort study in Japan. Br J Cancer 2009;100:181-4. 60. Guidelines for the prevention, care and treatment of persons with
42. Zhang W, Shu XO, Li H, Yang G, Cai H, Ji BT, Gao J, Gao YT, Zheng chronic hepatitis B infection. Avaliable from: http://apps.who.int/iris/
W, Xiang YB. Vitamin intake and liver cancer risk: a report from two bitstream/10665/154590/1/9789241549059_eng.pdf. [Last accessed
cohort studies in China. J Natl Cancer Inst 2012;104:1173-81. on 19 Oct 2017]
43. Liu Y, Chang CC, Marsh GM, Wu F. Population attributable risk of 61. Ekra D, Herbinger KH, Konate S, Leblond A, Fretz C, Cilote V, Douai
aflatoxin-related liver cancer: systematic review and meta-analysis. C, Da Silva A, Gessner BD, Chauvin P. A non-randomized vaccine
Eur J Cancer 2012;48:2125-36. effectiveness trial of accelerated infant hepatitis B immunization
44. Sun Z, Chen T, Thorgeirsson SS, Zhan Q, Chen J, Park JH, Lu schedules with a first dose at birth or age 6 weeks in Côte d’Ivoire.
P, Hsia CC, Wang N, Xu L, Lu L, Huang F, Zhu Y, Lu J, Ni Z, Vaccine 2008;26:2753-61.
Zhang Q, Wu Y, Liu G, Wu Z, Qu C, Gail MH. Dramatic reduction 62. Lau YL, Tam AY, Ng KW, Tsoi NS, Lam B, Lam P, Yeung CY.
of liver cancer incidence in young adults: 28 year follow-up of Response of preterm infants to hepatitis B vaccine. J Pediatr
etiological interventions in an endemic area of China. Carcinogenesis 1992;121:962-5.
2013;34:1800-5. 63. Freitas da Motta MS, Mussi-Pinhata MM, Jorge SM, Tachibana
45. Zhang W, Xiang YB, Li HL, Yang G, Cai H, Ji BT, Gao YT, Zheng Yoshida CF, Sandoval de Souza CB. Immunogenicity of hepatitis B
W, Shu XO. Vegetable-based dietary pattern and liver cancer risk: vaccine in preterm and full term infants vaccinated within the first
results from the Shanghai women’s and men’s health studies. Cancer week of life. Vaccine 2002;20:1557-62.
Sci 2013;104:1353-61. 64. Lu LL, Chen BX, Wang J, Wang D, Ji Y, Yi HG, Chen T, Zhang
46. Chen JG, Kensler TW. Changing rates for liver and lung cancers in Y, Petersen E, Li Q, Qu C. Maternal transmission risk and antibody
Qidong, China. Chem Res Toxicol 2014;27:3-6. levels against hepatitis B virus e antigen in pregnant women. Int J
47. Pol S. Hepatitis: HBV vaccine--the first vaccine to prevent cancer. Nat Infect Dis 2014;28:41-4.
Rev Gastroenterol Hepatol 2015;12:190-1. 65. Zou H, Chen Y, Duan Z, Zhang H, Pan C. Virologic factors associated
48. Karnik R, Singal AG. To “B” or not to “B”: efficacy of a neonatal with failure to passive-active immunoprophylaxis in infants born to
hepatitis B vaccination program to prevent primary liver cancer and HBsAg-positive mothers. J Viral Hepat 2012;19:e18-25.
end-stage liver disease. Gastroenterology 2015;148:1073-5. 66. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm
49. Chen JG, Zhu J, Parkin DM, Zhang YH, Lu JH, Zhu YR, Chen TY. SW, Janssen HL. Lamivudine treatment during pregnancy to prevent
Trends in the incidence of cancer in Qidong, China, 1978-2002. Int J perinatal transmission of hepatitis B virus infection. J Viral Hepat
Cancer 2006;119:1447-54. 2003;10:294-7.
50. Xia QJ. Liver cell cancer in the young and adolescent and its relation 67. Wiseman E, Fraser MA, Holden S, Glass A, Kidson BL, Heron
to hepatitis B virus (HBV). Zhonghua Zhong Liu Za Zhi 1984;6:413- LG, Maley MW, Ayres A, Locarnini SA, Levy MT. Perinatal
6. (in Chinese) transmission of hepatitis B virus: an Australian experience. Med J
51. Sun Z, Lu P, Gail MH, Pee D, Zhang Q, Ming L, Wang J, Wu Y, Liu Aust 2009;190:489-92.
G, Wu Y, Zhu Y. Increased risk of hepatocellular carcinoma in male 68. Singh AE, Plitt SS, Osiowy C, Surynicz K, Kouadjo E, Preiksaitis
hepatitis B surface antigen carriers with chronic hepatitis who have J, Lee B. Factors associated with vaccine failure and vertical
detectable urinary aflatoxin metabolite M1. Hepatology 1999;30:379- transmission of hepatitis B among a cohort of Canadian mothers and
83. infants. J Viral Hepat 2011;18:468-73.
52. Ming L, Thorgeirsson SS, Gail MH, Lu P, Harris CC, Wang N, Shao 69. Jaffe A, Brown RS Jr. A review of antiviral use for the treatment of
Y, Wu Z, Liu G, Wang X, Sun Z. Dominant role of hepatitis B virus chronic hepatitis B virus infection in pregnant women. Gastroenterol
and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, Hepatol (N Y) 2017;13:154-63.
China. Hepatology 2002;36:1214-20. 70. Brown RS Jr, McMahon BJ, Lok AS, Wong JB, Ahmed AT, Mouchli
53. Sun Z, Zhu Y, Stjernsward J, Hilleman M, Collins R, Zhen Y, Hsia MA, Wang Z, Prokop LJ, Murad MH, Mohammed K. Antiviral
CC, Lu J, Huang F, Ni Z. Design and compliance of HBV vaccination therapy in chronic hepatitis B viral infection during pregnancy: a
trial on newborns to prevent hepatocellular carcinoma and 5-year systematic review and meta-analysis. Hepatology 2016;63:319-33.
results of its pilot study. Cancer Detect Prev 1991;15:313-8. 71. Zhang H, Pan CQ, Pang Q, Tian R, Yan M, Liu X. Telbivudine or

Hepatoma Research ¦ Volume 3 ¦ October 25, 2017 239